The global cell imaging systems market size valued at $3.58 billion in 2020 and expected to reach $7.82 billion in 2027 at a CAGR of 11.8% during forecast period. Cell imaging is the study of living cells using time-lapse microscopy to obtain a better understanding of biological function through the study of cellular dynamics. As a result of technological improvements, scientists’ approaches to researching proteins, molecular interactions, and internal structures of cells, as well as cellular processes and biological activities. Instead of looking fixed cells, they can monitor cells to get a better understanding. Live cell imaging, which is important for understanding cell dynamics in fields including immunology, genetics, neurology, and microbiology, can provide more precise data. Technological advancements in the cell imaging systems market will help academic institutes, government bodies, pharmaceutical companies, and diagnostic laboratories. According to a poll conducted by Drug Discovery World Spring, nearly 21% of researchers favour and employ live cell imaging, with 31% planning to do so in the future. The capacity to automate the incubation and picture capture of any live cell analyser is the most crucial feature for researchers. Second, they place a premium on the equipment’s ability to track live cells. Over the projected period, more advancements in equipment technology are likely to meet these criteria and increase their utility.